Zoetis (ZTS) Short-Term Debt issuances (2013 - 2024)
Zoetis (ZTS) reported Short-Term Debt issuances of -$24.0 million for Q2 2024, down 2300.0% year-over-year from $1.1 million in Q3 2023, and down 214.29% quarter-over-quarter from $21.0 million in Q1 2024.
Zoetis (ZTS) Short-Term Debt issuances (2013 - 2024) Analysis & Trends
Zoetis (ZTS) has 12 years of Short-Term Debt issuances data on file, last reported at -$24.0 million in Q2 2024.
- Short-Term Debt issuances for Q2 2024 came in at -$24.0 million, down 2300.0% year-over-year; the trailing twelve-month figure through Mar 2025 was -$24.0 million (down 214.29% YoY), and the FY2024 annual result was -$3.0 million, down 400.0% from the prior year.
- Short-Term Debt issuances fell to -$24.0 million in Q2 2024 per ZTS's latest filing, from $21.0 million in the prior quarter.
- Over five years, Short-Term Debt issuances peaked at $21.0 million in Q1 2024 and troughed at -$24.0 million in Q2 2024.
- A 5-year average of $0.0 and a median of $1.0 million in 2020 frame the typical range for Short-Term Debt issuances.
- On a YoY basis, Short-Term Debt issuances climbed as much as 2000.0% in 2024 and fell as far as 2300.0% in 2024.
- A 5-year view of Short-Term Debt issuances shows it stood at $3.0 million in 2020, then sank by 233.33% to -$4.0 million in 2021, then soared by 75.0% to -$1.0 million in 2022, then jumped by 200.0% to $1.0 million in 2023, then plunged by 2500.0% to -$24.0 million in 2024.
- Business Quant data shows ZTS's Short-Term Debt issuances at -$24.0 million in Q2 2024, $21.0 million in Q1 2024, and $1.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ST Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -24.00 Mn |
| Jun 30, 2024 | -24.00 Mn |
| Mar 31, 2024 | 21.00 Mn |
| Mar 31, 2024 | 21.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | -1.00 Mn |
| Dec 31, 2022 | -1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Sep 30, 2021 | -4.00 Mn |
| Sep 30, 2021 | -4.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Dec 31, 2020 | 3.00 Mn |